Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

This study has been completed.
Information provided by (Responsible Party):
Hoseok Koo, Inje University Identifier:
First received: May 29, 2012
Last updated: June 4, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Estimated Primary Completion Date: No date given